For my migraine girlies 🫶

Living with chronic migraines for over a decade has been a relentless cycle of hope and disappointment. Each new medication brings its own set of challenges, and the physical and emotional exhaustion can be overwhelming. When I finally decided to try Aimovig (erenumab-aooe), I was both nervous and hopeful. The auto-injector shot, which delivers a 70 mg subcutaneous dose, was surprisingly easier than expected—a small but important win that adds encouragement to this uncertain journey. One aspect that has been particularly challenging is the 'wait and see' phase after starting a new treatment like Aimovig. Patience doesn’t come easy when dealing with chronic pain that disrupts every aspect of life. What has helped me is setting small, realistic expectations and tracking any changes in my migraine frequency or intensity. Keeping a migraine diary helps me stay engaged in the process and gives my healthcare provider valuable insights. I’ve also found that connecting with others who are on similar paths provides emotional support and practical tips. Many share strategies such as prioritizing hydration, maintaining a consistent sleep schedule, and avoiding known migraine triggers during the adjustment period. Additionally, gentle self-care practices like meditation and light stretching can lessen overall stress, which often exacerbates migraines. From my experience, it’s essential to communicate openly with your medical team about any side effects or concerns while on Aimovig. Since this medication is a relatively new preventive treatment targeting the CGRP pathway involved in migraine pain, responses can vary. Some people notice improvements within weeks, while others may take several months. Staying informed and patient is key. Ultimately, while Aimovig represents a promising new option for migraine prevention, the journey is deeply personal and often requires ongoing self-advocacy. I encourage anyone transitioning medications to embrace each small victory and seek community support to navigate the ups and downs of chronic migraine management.